UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

BMC cancer, 2011-01, Vol.11 (1), p.1-1, Article 1

2011

Volltextzugriff (PDF)

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

PloS one, 2017-08, Vol.12 (8), p.e0183976-e0183976

2017

Volltextzugriff (PDF)

Interlanguage pragmatics study of indirect complaint among Japanese ESL learners

Sino-US English teaching, 2010-12, Vol.7 (12), p.23-32

Baba, Junko

2010

Volltextzugriff (PDF)

Pragmatic function of Japanese mimetics in the spoken discourse of varying emotive intensity levels

Journal of pragmatics, 2003-12, Vol.35 (12), p.1861-1889

Baba, Junko

2003

Volltextzugriff (PDF)

P76-1 Comparison of programmed death ligand-1 expression in NSCLC using 22C3 and SP142 antibodies in a single institute study

Annals of oncology, 2022-07, Vol.33, p.S543

2022

Volltextzugriff (PDF)

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

Oncology, 2018-03, Vol.94 (4), p.223-232

2018

Volltextzugriff (PDF)

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia

Blood, 2012-09, Vol.120 (12), p.2417-2427

2012

Volltextzugriff (PDF)

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

The Journal of immunology (1950), 2015-07, Vol.195 (2), p.726-735

2015

Volltextzugriff (PDF)

Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells

Middle East journal of cancer, 2011-01, Vol.2 (1), p.9-18

2011

Volltextzugriff (PDF)

Abstract 3206: Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3206-3206

2016

Volltextzugriff (PDF)

Abstract 3206: Programmed death receptor-1programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3206-3206

2016

Volltextzugriff (PDF)

The activity report of the OUG Patent Group(<Special feature>Activity reports on OUG/SIG of INFOSTA)

The Journal of Information Science and Technology Association, 2010/05/01, Vol.60(5), pp.183-184

BABA, Junko

2010

Volltextzugriff (PDF)

Management of Adverse Events Induced by Immune Checkpoint Inhibitors in Lung Cancer Treatment

Haigan, 2019/06/20, Vol.59(3), pp.231-237

2019

Volltextzugriff (PDF)

Management of Adverse Events Induced by Immune Checkpoint Inhibitors in Lung Cancer Treatment

Haigan. Lung cancer, 2019-06, Vol.59 (3), p.231-237

2019

Volltextzugriff (PDF)

Abstract 3153: Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3153-3153

2015

Volltextzugriff (PDF)

Abstract 2818: Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2818-2818

2014

Volltextzugriff (PDF)

Abstract 3963: Chemo-resistantregulatory T cells suppress the development of antitumor immunity aftercytotoxic regimens

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3963-3963

2013

Volltextzugriff (PDF)

Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

Cancer Immunology, Immunotherapy, 2011-11, Vol.60 (11), p.1597-1608

2011

Volltextzugriff (PDF)

Abstract 1550: Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1550-1550

2012

Volltextzugriff (PDF)

Abstract 2694: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133+ tumor-specific protein and induces antitumor immunity

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2694-2694

2011

Volltextzugriff (PDF)

Abstract 2685: Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naïve mice augments antitumor response

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2685-2685

2011

Volltextzugriff (PDF)

Abstract 1920: Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1920-1920

2010

Volltextzugriff (PDF)

Vaccination with CD133^sup +^ melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

Cancer immunology, immunotherapy, 2011-11, Vol.60 (11), p.1597

2011

Volltextzugriff (PDF)

Vaccination with CD133 super(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

Cancer Immunology, Immunotherapy, 2011-11, Vol.60 (11), p.1597-1608

2011

Volltextzugriff (PDF)

Abstract 5165: Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5165-5165

2010

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(263)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(153)
Humans
(117)
Female
(93)
Male
(85)
Animals
(49)
Biological And Medical Sciences
(44)
Japan
(44)
Aged
(43)
Middle Aged
(43)
Adult
(32)
Diet
(32)
Risk Factors
(31)
Surveys And Questionnaires
(27)
Neurosciences & Neurology
(26)
Nutrition & Dietetics
(26)
Fundamental And Applied Biological Sciences. Psychology
(25)
Adolescent
(24)
Oncology
(23)
Japan - Epidemiology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

Interlanguage pragmatics study of indirect complaint among Japanese ESL learners

Pragmatic function of Japanese mimetics in the spoken discourse of varying emotive intensity levels

P76-1 Comparison of programmed death ligand-1 expression in NSCLC using 22C3 and SP142 antibodies in a single institute study

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells

Abstract 3206: Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies

Abstract 3206: Programmed death receptor-1programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies

The activity report of the OUG Patent Group(<Special feature>Activity reports on OUG/SIG of INFOSTA)

Management of Adverse Events Induced by Immune Checkpoint Inhibitors in Lung Cancer Treatment

Management of Adverse Events Induced by Immune Checkpoint Inhibitors in Lung Cancer Treatment

Abstract 3153: Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation

Abstract 2818: Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy

Abstract 3963: Chemo-resistantregulatory T cells suppress the development of antitumor immunity aftercytotoxic regimens

Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

Abstract 1550: Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells

Abstract 2694: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133+ tumor-specific protein and induces antitumor immunity

Abstract 2685: Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naïve mice augments antitumor response

Abstract 1920: Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation

Vaccination with CD133^sup +^ melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

Vaccination with CD133 super(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

Abstract 5165: Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo

Suchergebnisse filtern